United States· US:71335-0777_bc883971-73e7-43b2-8b10-840c87eaa79e
clonidine hydrochloride
A medicinal product containing clonidine hydrochloride, registered in United States by Bryant Ranch Prepack.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CLONIDINE HYDROCHLORIDE
- Manufacturer
- Bryant Ranch Prepack
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 20
- ndc11713350777024 TABLET in 1 BOTTLE (71335-0777-0)
- ndc117133507771100 TABLET in 1 BOTTLE (71335-0777-1)
- ndc11713350777230 TABLET in 1 BOTTLE (71335-0777-2)
- ndc11713350777320 TABLET in 1 BOTTLE (71335-0777-3)
- ndc11713350777460 TABLET in 1 BOTTLE (71335-0777-4)
- ndc117133507775120 TABLET in 1 BOTTLE (71335-0777-5)
- ndc11713350777690 TABLET in 1 BOTTLE (71335-0777-6)
- ndc11713350777710 TABLET in 1 BOTTLE (71335-0777-7)
- ndc11713350777845 TABLET in 1 BOTTLE (71335-0777-8)
- ndc11713350777914 TABLET in 1 BOTTLE (71335-0777-9)
- ndc1171335-0777-0
- ndc1171335-0777-1
- ndc1171335-0777-2
- ndc1171335-0777-3
- ndc1171335-0777-4
- ndc1171335-0777-5
- ndc1171335-0777-6
- ndc1171335-0777-7
- ndc1171335-0777-8
- ndc1171335-0777-9
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Clonidine hydrochloride in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaCLONIDINESIVEM PHARMACEUTICALS ULC
- United KingdomCatapres 100microgram tabletsGlenwood GmbH
- IrelandCatapres Tablets 100 microgramsGlenwood GmbH
- NorwayCaruxinMacure Pharma ApS
- GermanyAlcaridinCarinopharm Gmbh
- SwedenCaruxin 150 mikrogram/ml Injektionsvätska, lösningMACURE PHARMA ApS
- FinlandCaprysinSchering Oy
- NetherlandsCatapresan, oplossing voor injectie 0,150 mg/mlGlenwood GmbH Pharmazeutische Erzeugnisse
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Catapresan
- Belgium · Catapressan
- Bulgaria · Хлофазолин
- Czechia · Clonidine Olikla
- Germany · Alcaridin, Catapresan
- Denmark · Caruxin, Clopressan
- Spain · Catapresan
- Finland · Catapresan, Clonidine Macure
- France · Catapressan
- United Kingdom (Northern Ireland) · Calotep, Catapres
- Greece · Catapresan
- Ireland · Catapres, Catapres Ampoules
- Italy · Catapresan, Catapresan Tts-1
- Luxembourg · Catapressan
- Latvia · Chlophazolin
- Malta · Alcaridin, Catapres Tablets
- Netherlands · Catapresan, Clonidine Hcl Cf
- Norway · Caruxin, Clotaxip
- Poland · Iporel
- Portugal · Catapresan, Edolglau
- Romania · Clonidină Arena, Clonidina Sintofarm
- Sweden · Caruxin, Catapresan
- Slovakia · Clonidine Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db4df962-7db0-41c4-99e4-fb27f46f3650 GET /v1/drugs/db4df962-7db0-41c4-99e4-fb27f46f3650?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": ".1",
"substance": "CLONIDINE HYDROCHLORIDE",
"productndc": "71335-0777",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA091368",
"marketing_category": "ANDA"
}See everything about clonidine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.